德源药业
(832735)
| 流通市值：41.05亿 | | | 总市值：46.41亿 |
| 流通股本：1.04亿 | | | 总股本：1.17亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 176,144,690.98 | 306,031,517.29 | 301,072,011.45 | 305,146,182.79 |
| 应收票据及应收账款 | 231,306,036.96 | 221,329,064.25 | 225,863,440.04 | 240,118,780.82 |
| 其中：应收票据 | 60,103,251.3 | 63,775,614.4 | 56,143,897.97 | 65,454,474.43 |
| 应收账款 | 171,202,785.66 | 157,553,449.85 | 169,719,542.07 | 174,664,306.39 |
| 预付款项 | 953,495.01 | 1,716,774.82 | 776,796.11 | 608,982.74 |
| 其他应收款合计 | 377,915.39 | 130,794.94 | 235,528.25 | 203,071.13 |
| 存货 | 80,713,343.22 | 70,141,316.89 | 61,154,187.73 | 63,836,948.02 |
| 其他流动资产 | 64,292.11 | 15,489.15 | 325,871.29 | 138,387.42 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 782,299,815.24 | 789,431,642.27 | 779,824,300.61 | 773,369,366.24 |
| 非流动资产: | | | | |
| 长期股权投资 | 9,132,125.18 | 9,195,431.41 | 9,543,050.01 | 9,165,181.12 |
| 其他权益工具投资 | 4,000,000 | 4,000,000 | 4,000,000 | 4,000,000 |
| 固定资产 | 150,765,882.34 | 152,395,709.78 | 130,555,149.9 | 134,008,720.81 |
| 在建工程 | 304,056,044.12 | 283,909,848.42 | 270,576,910.17 | 214,737,470.53 |
| 使用权资产 | 1,875,738.09 | 2,076,710.03 | 2,277,681.97 | 59,135.36 |
| 无形资产 | 49,894,585.55 | 50,275,808.93 | 50,657,594.87 | 51,039,662.27 |
| 长期待摊费用 | 570,999.83 | 636,477.41 | 238,805.13 | 268,655.79 |
| 递延所得税资产 | 9,146,123.8 | 9,305,415.42 | 4,978,058.94 | 5,831,587.12 |
| 其他非流动资产 | 123,857,033.25 | 83,186,738.32 | 63,430,419.39 | 31,995,406.58 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 653,298,532.16 | 594,982,139.72 | 536,257,670.38 | 451,105,819.58 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,435,598,347.4 | 1,384,413,781.99 | 1,316,081,970.99 | 1,224,475,185.82 |
| 流动负债: | | | | |
| 短期借款 | 27,112,897.11 | 27,112,897.11 | 27,110,815.55 | 18,104,773.88 |
| 应付票据及应付账款 | 127,171,879.18 | 136,224,265.86 | 134,743,213.29 | 108,251,678.63 |
| 其中：应付票据 | 41,297,196.3 | 36,496,488.13 | 39,541,664.56 | 27,598,507.76 |
| 应付账款 | 85,874,682.88 | 99,727,777.73 | 95,201,548.73 | 80,653,170.87 |
| 合同负债 | 2,519,769.71 | 2,512,643.79 | 3,714,722.41 | 2,230,155.03 |
| 应付职工薪酬 | 22,502,772.2 | 25,038,590.75 | 29,199,296.63 | 23,021,919.81 |
| 应交税费 | 23,550,937.74 | 9,378,865.04 | 28,031,079.2 | 18,501,254.88 |
| 其他应付款合计 | 23,726,957.79 | 20,834,678.47 | 20,260,778.8 | 21,434,565.21 |
| 一年内到期的非流动负债 | 781,020.14 | 803,669.73 | 1,080,657.93 | 7,992,052.2 |
| 其他流动负债 | 327,570.06 | 326,643.69 | 482,913.91 | 289,920.15 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 227,693,803.93 | 222,232,254.44 | 244,623,477.72 | 199,826,319.79 |
| 非流动负债: | | | | |
| 租赁负债 | 834,526.01 | 800,305.31 | 788,734.2 | - |
| 递延收益 | 54,688,444.54 | 55,442,616.22 | 26,426,787.9 | 23,801,183.81 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 55,522,970.55 | 56,242,921.53 | 27,215,522.1 | 23,801,183.81 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 283,216,774.48 | 278,475,175.97 | 271,838,999.82 | 223,627,503.6 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 78,210,660 | 78,210,660 | 78,245,040 | 78,245,040 |
| 资本公积 | 401,669,189.15 | 401,669,189.15 | 401,919,850.6 | 401,328,482.54 |
| 减:库存股 | - | - | 280,163.4 | 7,995,227.4 |
| 盈余公积 | 42,279,526.38 | 42,279,526.38 | 42,279,526.38 | 42,279,526.38 |
| 未分配利润 | 630,222,197.39 | 583,779,230.49 | 522,078,717.59 | 486,989,860.7 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,152,381,572.92 | 1,105,938,606.02 | 1,044,242,971.17 | 1,000,847,682.22 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,152,381,572.92 | 1,105,938,606.02 | 1,044,242,971.17 | 1,000,847,682.22 |
| 负债和股东权益合计 | 1,435,598,347.4 | 1,384,413,781.99 | 1,316,081,970.99 | 1,224,475,185.82 |
| 公告日期 | 2025-04-28 | 2025-03-31 | 2024-10-25 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |